An atypical tumor necrosis factor (TNF) receptor-associated factor-binding motif of B cell-activating factor belonging to the TNF family (BAFF) receptor mediates induction of the noncanonical NF-kappaB signaling pathway.
about
TRAF3 controls activation of the canonical and alternative NFkappaB by the lymphotoxin beta receptorCD40 in coronary artery disease: a matter of macrophages?Roles of tumor necrosis factor receptor associated factor 3 (TRAF3) and TRAF5 in immune cell functionsNon-Canonical NF-κB Signaling Initiated by BAFF Influences B Cell Biology at Multiple JuncturesOTUD7B controls non-canonical NF-κB activation through deubiquitination of TRAF3Participation of B-cell-activating factor receptors in the pathogenesis of immune thrombocytopenia.The TRAF3 adaptor protein drives proliferation of anaplastic large cell lymphoma cells by regulating multiple signaling pathways.The nuclear factor-kappaB-interleukin-6 signalling pathway mediating vascular inflammation.A BAFF-R mutation associated with non-Hodgkin lymphoma alters TRAF recruitment and reveals new insights into BAFF-R signaling.Nuclear factor-κB-inducing kinase (NIK) contains an amino-terminal inhibitor of apoptosis (IAP)-binding motif (IBM) that potentiates NIK degradation by cellular IAP1 (c-IAP1).Constitutive BR3 receptor signaling in diffuse, large B-cell lymphomas stabilizes nuclear factor-κB-inducing kinase while activating both canonical and alternative nuclear factor-κB pathways.Autosomal-dominant B-cell deficiency with alopecia due to a mutation in NFKB2 that results in nonprocessable p100.Noncanonical NF-kappaB regulates inducible costimulator (ICOS) ligand expression and T follicular helper cell development.Differential expression of the adaptor protein HSH2 controls the quantitative and qualitative nature of the humoral response.TNF superfamily protein-protein interactions: feasibility of small- molecule modulationCrucial role for TNF receptor-associated factor 2 (TRAF2) in regulating NFκB2 signaling that contributes to autoimmunityBAFF promotes proliferation of human mesangial cells through interaction with BAFF-RInnate and Adaptive Immunity in Calcific Aortic Valve DiseaseSite-specific ubiquitination is required for relieving the transcription factor Miz1-mediated suppression on TNF-α-induced JNK activation and inflammation.Targeting signaling factors for degradation, an emerging mechanism for TRAF functionsChimeric Vaccine Stimulation of Human Dendritic Cell Indoleamine 2, 3-Dioxygenase Occurs via the Non-Canonical NF-κB Pathway.Tumor necrosis factor receptor-associated factor 3 is a critical regulator of B cell homeostasis in secondary lymphoid organsRole of BAFF and APRIL in human B-cell chronic lymphocytic leukaemia.SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survival.Antibody deficiency associated with an inherited autosomal dominant mutation in TWEAK.B cell survival: an unexpected mechanism of lymphocyte vitality.BAFF-R promotes cell proliferation and survival through interaction with IKKbeta and NF-kappaB/c-Rel in the nucleus of normal and neoplastic B-lymphoid cells.TRAF2 and TRAF3 independently mediate Ig class switching driven by CD40.NF-κB inducing kinase: a key regulator in the immune system and in cancerNon-canonical NF-κB signaling pathway.Roles for TNF-receptor associated factor 3 (TRAF3) in lymphocyte functions.Signaling mechanisms regulating B-lymphocyte activation and tolerance.Genetics of common variable immunodeficiency: role of transmembrane activator and calcium modulator and cyclophilin ligand interactor.Development of a Novel BAFF Responsive Cell Line Suitable for Detecting Bioactive BAFF and Neutralizing Antibodies against BAFF-Pathway Inhibiting Therapeutics.Impairment of Mature B Cell Maintenance upon Combined Deletion of the Alternative NF-κB Transcription Factors RELB and NF-κB2 in B Cells.B Cell-Activating Factor (BAFF)-Targeted B Cell Therapies in Inflammatory Bowel Diseases.The non-canonical NF-κB pathway in immunity and inflammation.B-cell-activating factor and autoimmune myasthenia gravis.B-lymphocyte stimulator/a proliferation-inducing ligand heterotrimers are elevated in the sera of patients with autoimmune disease and are neutralized by atacicept and B-cell maturation antigen-immunoglobulin.Analysis of the regulatory role of BAFF in controlling the expression of CD21 and CD23.
P2860
Q24300996-21586C27-A258-4487-AA62-7206FEDD476DQ26752784-87FB1E46-42CD-47FD-9163-8D7CC92CB456Q26853280-2C2324AA-BE2B-44AA-B432-2CAAA2184BD6Q27024640-CE4AD260-8A26-45B7-8EE0-CD15530B3945Q28513798-74EAC7B0-A401-4B18-B3E8-563B8B57A766Q33429051-49D946E4-EE69-4058-9E9A-630B661E43E3Q33953115-9229D581-6FD3-48A8-81B5-6375A83C2F52Q34030580-9CC2D1CA-F87E-4A38-81F3-925DEB895899Q34340672-C7CF099E-A406-4906-8578-15597C04BEFEQ34431075-A56ACE4B-1883-4E0A-9297-8124956A4894Q34568850-4FDEC779-9E25-4282-8098-CC441C2199E3Q35062895-35672236-2236-4D82-BE31-4B074C6E44BAQ35149531-062FAA85-866F-48ED-BFCB-7B923C746156Q35228256-5D3FFB8F-E9B5-40EE-9524-F3EFBAE1E4DFQ35534271-96ABD44D-3984-4B52-AEDA-D69EDD650B62Q35546725-8DA53620-48D4-4C3D-8557-D7822AEE80E3Q35608647-AB57EF5E-4917-423F-A21C-D5C709FEAF4DQ35612638-AD8C9D0D-23AA-4B4B-91EA-853970084A38Q35657765-04EE49A5-8159-4491-A02A-24C78FA70F78Q35759267-AF3FDE82-B7E3-4D56-AE35-1C67C468C61BQ35924786-87E7F1DF-A2F0-40FE-8CF3-A64500E8601FQ36156167-986C96B9-AC3F-4BA0-ABAC-F77B7AC7C2C5Q36530420-AACFD51D-9ADC-4531-849E-DC7C73C7E9D0Q36545934-C1C7EE87-86C4-4470-A2AB-57180330947AQ36729652-6C01F097-025F-45F8-A296-696B12150586Q37168165-EB48E9DF-3CD1-4A5F-85E4-1F2A9066A2F6Q37187531-D3C87602-D30C-4BAA-BA40-CB967E745331Q37291416-DB4D3FE2-0DC0-4DEC-AC29-1AB6C9AD1855Q37777775-ABD4796A-1766-42F1-9B6B-3F98366F27EAQ37822660-4822A602-B8DE-4C52-9472-8ECEB6CABB14Q38179139-43BFE816-3F61-48CE-845C-0EDFCC98DC7AQ38334794-C1DADB10-95B4-49B6-9900-FCAD3AB034E8Q38533817-A6D74F8C-BCE9-4B89-A36E-CE9DBDBAD927Q38673541-6CE2B637-6790-476B-8F84-0763D83C0CC9Q38798777-61727695-1F0D-4AAC-ADD8-A50B1A8368C7Q38961202-B2DDFE74-4899-4D64-A44D-7555E64E65DDQ39350735-79CEB85E-7306-4541-8610-EFEC7A19C676Q40179681-D11F443C-1F99-444B-8C3C-44A22D4B6EAFQ41182083-1D2C0C1D-8859-4D30-866D-5788EE68C050Q41762909-CE47554C-E7F5-43AF-893D-B2D61F751CE6
P2860
An atypical tumor necrosis factor (TNF) receptor-associated factor-binding motif of B cell-activating factor belonging to the TNF family (BAFF) receptor mediates induction of the noncanonical NF-kappaB signaling pathway.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
An atypical tumor necrosis fac ...... l NF-kappaB signaling pathway.
@en
type
label
An atypical tumor necrosis fac ...... l NF-kappaB signaling pathway.
@en
prefLabel
An atypical tumor necrosis fac ...... l NF-kappaB signaling pathway.
@en
P2093
P2860
P356
P1476
An atypical tumor necrosis fac ...... l NF-kappaB signaling pathway.
@en
P2093
Matthew D Morrison
Minying Zhang
Shao-Cong Sun
William Reiley
P2860
P304
10018-10024
P356
10.1074/JBC.M413634200
P407
P577
2005-01-11T00:00:00Z